ASCO Backs Central IRB For Cancer Trials, Stiffens Conflict-of-Interest Policies
Duke Picks Lyerly To Direct Cancer Center
Parkinson Heads Oncology At Amgen
NCI Says Men Should Eat 9 Fruits/Vegetables A Day, Begins Campaign Targeting Black Men
16 Institutions Win NCI Awards for Phase I Trials
EPIC, PLCO Studies Show High Fiber Diet Cuts Cancer Risk
Funding Opportunities. (8-page issue).
Includes April issue of Business & Regulatory Report (8 pages).
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- The Directors: New directors Herbst and Gius chart a future built on AI, collaboration, and rural access
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial - Consumers are increasingly accessing U.S. News rankings of cancer hospitals via AI chatbots
2026 report shows no change in the top-five lineup - What happened at FDA? Replimune approval raises questions









